ACR Appropriateness Criteria® on Postmastectomy Radiotherapy. Expert Panel on Radiation Oncology-Breast

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 4, 2009, Pages 997-1002

  Taylor, Marie E ^a   Haffty, Bruce G ^b   Rabinovitch, Rachel ^c   Arthur, Douglas W ^d   Halberg, Francine E ^e   Strom, Eric A ^f   White, Julia R ^g   Cobleigh, Melody A ^h   Edge, Stephen B ⁱ  

^a WASHINGTON UNIVERSITY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Marin Cancer Institute   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g MEDICAL COLLEGE OF WISCONSIN   (United States)

^h RUSH UNIVERSITY MEDICAL CENTER   (United States)

ⁱ ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Adjuvant therapy; Appropriateness Criteria; Breast cancer; Postmastectomy; Radiation therapy

Indexed keywords

PATIENT MONITORING;

ADJUVANT THERAPY; APPROPRIATENESS CRITERIA; BREAST CANCER; POSTMASTECTOMY; RADIATION THERAPY;

RADIOTHERAPY;

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL TRIAL; COBALT TELETHERAPY; DISEASE FREE SURVIVAL; ERYTHEMA; HUMAN; IRRADIATION; LYMPH NODE METASTASIS; MASTECTOMY; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION FIELD; RADIATION HAZARD; RADIOSENSITIVITY; REVIEW; THORAX WALL; TREATMENT FAILURE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, RADIATION-INDUCED; POSTMENOPAUSE; PREMENOPAUSE; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SKIN NEOPLASMS;

EID: 61549121681     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.10.080     Document Type: Review

References (50)

1. Arriagada R., Rutqvist L.E., Mattsson A., et al. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol 13 (1995) 2869-2878
2. Axelsson C.K., and Blichert-Toft M. Low-risk breast cancer patients treated by mastectomy and lower axillary dissection. The present status of the Danish Breast Cancer Cooperative Group Trial 77-A. Acta Oncol 27 (1988) 605-609
3. Fisher B., Dignam J., Mamounas E.P., et al. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: Eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil. J Clin Oncol 14 (1996) 1982-1992
4. Morrison J.M., Kelly K.A., Howell A., et al. West Midlands Oncology Association trial of adjuvant chemotherapy in node-negative breast cancer. J Natl Cancer Inst Monogr 11 (1992) 85-88
5. Senn H.J., Barett-Mahler A.R., Jungi W.F., et al. Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients: 10 year results. Eur J Cancer Clin Oncol 25 (1989) 513-525
6. Castiglione-Gertsch M., Johnsen C., Goldhirsch A., et al. The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up. Ann Oncol 5 (1994) 717-724
7. Fisher B., Fisher E.R., and Redmond C. Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. J Clin Oncol 4 (1986) 929-941
8. Morrison J.M., Howell A., Kelly K.A., et al. West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. I. Patients with involved axillary lymph nodes. Br J Cancer 60 (1989) 911-918
9. Richards M.A., O'Reilly S.M., Howell A., et al. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: An update of the Guy's/Manchester trial. J Clin Oncol 8 (1990) 2032-2039
10. Rubens R.D., Hayward J.L., Knight R.K., et al. Controlled trial of adjuvant chemotherapy with melphalan for breast cancer. Lancet 1 (1983) 839-843
11. Fowble B., Gray R., Gilchrist K., et al. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol 6 (1988) 1107-1117
12. Jagsi R., Raad R.A., Goldberg S., et al. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: Implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys 62 (2005) 1035-1039
13. Lee J.C., Truong P.T., Kader H.A., et al. Postmastectomy radiotherapy reduces locoregional recurrence in elderly women with high-risk breast cancer. Clin Oncol (R Coll Radiol) 17 (2005) 623-629
14. Pisansky T.M., Ingle J.N., Schaid D.J., et al. Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer. Impact of clinical, histopathologic, and flow cytometric factors. Cancer 72 (1993) 1247-1260
15. Recht A., Gray R., Davidson N.E., et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group. J Clin Oncol 17 (1999) 1689-1700
16. Taghian A., Jeong J.H., Mamounas E., et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 22 (2004) 4247-4254
17. Truong P.T., Lee J., Kader H.A., et al. Locoregional recurrence risks in elderly breast cancer patients treated with mastectomy without adjuvant radiotherapy. Eur J Cancer 41 (2005) 1267-1277
18. Ahlborn T.N., Gump F.E., Bodian C., et al. Tumor to fascia margin as a factor in local recurrence after modified radical mastectomy. Surg Gynecol Obstet 166 (1988) 523-526
19. Huang E.H., Tucker S.L., Strom E.A., et al. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 351-357
20. Haagensen C.D. Diseases of the breast. 3rd ed (1986), W.B. Saunders, Philadelphia
21. Nielsen H.M., Overgaard M., Grau C., et al. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: Long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol 24 (2006) 2268-2275
22. Recht A., Hayes D.F., Eberlein T.J., et al. Local-regional recurrence after mastectomy or breast- conserving therapy. In: Harris J.R., Lippman M.E., Morrow M., et al. (Eds). Diseases of the breast (1996), J.B. Lippincott, Philadelphia 649-667
23. Recht A., and Houlihan M.J. Axillary lymph nodes and breast cancer: A review. Cancer 76 (1995) 1491-1512
24. Recht A., Pierce S.M., Abner A., et al. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 9 (1991) 988-996
25. Buchholz T.A., Katz A., Strom E.A., et al. Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy. Int J Radiat Oncol Biol Phys 53 (2002) 880-888
26. Donegan W.L., Stine S.B., and Samter T.G. Implications of extracapsular nodal metastases for treatment and prognosis of breast cancer. Cancer 72 (1993) 778-782
27. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353 (1999) 1641-1648
28. Pierce L.J., Oberman H.A., Strawderman M.H., et al. Microscopic extracapsular extension in the axilla: Is this an indication for axillary radiotherapy?. Int J Radiat Oncol Biol Phys 33 (1995) 253-259
29. Hetelekidis S., Schnitt S.J., Silver B., et al. The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancer. Int J Radiat Oncol Biol Phys 46 (2000) 31-34
30. Garg A.K., Strom E.A., McNeese M.D., et al. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in Stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 59 (2004) 138-145
31. Bonadonna G., Valagussa P., Moliterni A., et al. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: The results of 20 years of follow-up. N Engl J Med 332 (1995) 901-906
32. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337 (1997) 949-955
33. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337 (1997) 956-962
34. Overgaard M., Nielsen H.M., and Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol 82 (2007) 247-253
35. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366 (2005) 2087-2106
36. Smith B.D., Smith G.L., and Haffty B.G. Postmastectomy radiation and mortality in women with T1-2 node-positive breast cancer. J Clin Oncol 23 (2005) 1409-1419
37. Darby S.C., McGale P., Taylor C.W., et al. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 6 (2005) 557-565
38. Gebski V., Lagleva M., Keech A., et al. Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: A clinical perspective. J Natl Cancer Inst 98 (2006) 26-38
39. Thoms Jr. W.W., McNeese M.D., Fletcher G.H., et al. Multimodal treatment for inflammatory breast cancer. Int J Radiat Oncol Biol Phys 17 (1989) 739-745
40. Richter C., Kuhn T., Becker A., et al. Acute normal tissue reaction and local control in breast cancer patients with postmastectomy radiotherapy. [abstract]. Int J Radiat Oncol Biol Phys 36 (1996) 285
41. Fletcher G.H., McNeese M.D., and Oswald M.J. Long-range results for breast cancer patients treated by radical mastectomy and postoperative radiation without adjuvant chemotherapy: An update. Int J Radiat Oncol Biol Phys 17 (1989) 11-14
42. Owen J.R., Ashton A., Bliss J.M., et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: Long-term results of a randomised trial. Lancet Oncol 7 (2006) 467-471
43. Shelley W., Brundage M., Hayter C., et al. A shorter fractionation schedule for postlumpectomy breast cancer patients. Int J Radiat Oncol Biol Phys 47 (2000) 1219-1228
44. Whelan T., MacKenzie R., Julian J., et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 94 (2002) 1143-1150
45. Yarnold J., Ashton A., Bliss J., et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: Long-term results of a randomised trial. Radiother Oncol 75 (2005) 9-17
46. Marhin W., Wai E., and Tyldesley S. Impact of fraction size on cardiac mortality in women treated with tangential radiotherapy for localized breast cancer. Int J Radiat Oncol Biol Phys 69 (2007) 483-489
47. Sheldon T., Hayes D.F., Cady B., et al. Primary radiation therapy for locally advanced breast cancer. Cancer 60 (1987) 1219-1225
48. Pierce S.M., Recht A., Lingos T.I., et al. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys 23 (1992) 915-923
49. Griem K.L., Henderson I.C., Gelman R., et al. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J Clin Oncol 5 (1987) 1546-1555
50. Harris J.R., and Morrow M. Local management of invasive breast cancer. In: Harris J.R., Lippman M.E., Morrow M., et al. (Eds). Diseases of the breast. 3rd ed (2004), J.B. Lippincott, Philadelphia 719-799